Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael J. Welsh currently holds 12,540 shares of CANCER GENETICS, INC (CGIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Welsh has been a net buyer of CGIX stock. They have purchased $97 and sold $0 worth of shares.
Michael J. Welsh's most recent insider trade was on Sep 28, 2017, when they sold 2,500 shares at $0.00 per share.
Michael J. Welsh serves as Executive at CANCER GENETICS, INC (CGIX). They have executed 4 insider transactions totaling $97 over their tenure at the company.
Michael J. Welsh holds the position of Executive at CANCER GENETICS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Michael J. Welsh has shown a buying trading pattern, with $97 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael J. Welsh was on Mar 16, 2016, when they purchased $97 worth of CGIX shares. This transaction involved 40 shares at $2.42 per share.
Michael J. Welsh currently owns 12,540 shares of CANCER GENETICS, INC (CGIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael J. Welsh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael J. Welsh has 4 Form 4 filings on record as an insider at CANCER GENETICS, INC.
Set alerts for Michael J. Welsh and 40,000+ other insiders.